PLA2R1 and membranous glomerulonephritis: A kidney biopsy, performed in December 2019, revealed stage two membranous nephropathy with negativity for anti-PLA2R and positivity for anti-IgG1(++), -IgG2(+/−), -IgG3(++), and -IgG4(+++) on immunofluorescence staining.